309 related articles for article (PubMed ID: 19357715)
1. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.
Wolfe JH; Sands MS; Harel N; Weil MA; Parente MK; Polesky AC; Reilly JJ; Hasson C; Weimelt S; Haskins ME
Mol Ther; 2000 Dec; 2(6):552-61. PubMed ID: 11124056
[TBL] [Abstract][Full Text] [Related]
3. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
[TBL] [Abstract][Full Text] [Related]
5. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
Gao C; Sands MS; Haskins ME; Ponder KP
Mol Ther; 2000 Sep; 2(3):233-44. PubMed ID: 10985954
[TBL] [Abstract][Full Text] [Related]
7. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
Moullier P; Bohl D; Heard JM; Danos O
Nat Genet; 1993 Jun; 4(2):154-9. PubMed ID: 8348154
[TBL] [Abstract][Full Text] [Related]
8. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
Daly TM; Ohlemiller KK; Roberts MS; Vogler CA; Sands MS
Gene Ther; 2001 Sep; 8(17):1291-8. PubMed ID: 11571565
[TBL] [Abstract][Full Text] [Related]
9. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
Karolewski BA; Wolfe JH
Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
[TBL] [Abstract][Full Text] [Related]
10. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
[TBL] [Abstract][Full Text] [Related]
11. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
[TBL] [Abstract][Full Text] [Related]
12. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
[TBL] [Abstract][Full Text] [Related]
13. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
[TBL] [Abstract][Full Text] [Related]
14. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
Bosch A; Perret E; Desmaris N; Heard JM
Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
[TBL] [Abstract][Full Text] [Related]
15. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer.
Wolfe JH; Sands MS; Barker JE; Gwynn B; Rowe LB; Vogler CA; Birkenmeier EH
Nature; 1992 Dec 24-31; 360(6406):749-53. PubMed ID: 1465145
[TBL] [Abstract][Full Text] [Related]
16. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
[TBL] [Abstract][Full Text] [Related]
17. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
[TBL] [Abstract][Full Text] [Related]
18. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
Poorthuis BJ; Romme AE; Willemsen R; Wagemaker G
Pediatr Res; 1994 Aug; 36(2):187-93. PubMed ID: 7970933
[TBL] [Abstract][Full Text] [Related]
20. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]